source
- CRISPR-based epigenetic editing shows promise in silencing hepatitis B genesA new CRISPR-based technique targets the epigenome to turn off genes that drive chronic hepatitis B infection, doing so without changing the underlying DNA sequence. Tune Therapeutics reported ear…